Patents by Inventor Martin CUMMINS

Martin CUMMINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES
    Publication number: 20240016898
    Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 18, 2024
    Applicant: Xeris Pharmaceuticals, Inc.
    Inventors: Steven PRESTRELSKI, Brett NEWSWANGER, Martin CUMMINS, Michael RIDDELL
  • TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES
    Publication number: 20210008170
    Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
    Type: Application
    Filed: December 21, 2018
    Publication date: January 14, 2021
    Applicant: XERIS PHARMACEUTICALS, INC.
    Inventors: Steven PRESTRELSKI, Brett NEWSWANGER, Martin CUMMINS, Michael RIDDELL